The right answer at the right time
Take a deep dive into our science
In partnership with both big pharma companies and biotechs we create solutions that few can offer. Solutions delivering vital insights that allow our partners to make the right decisions for clinical programmes. Solutions including innovative, complex mechanistic studies as well as large-scale, global, multi-centre imaging trials.
Here you can find some examples of what we do, combining imaging excellence with extensive drug development expertise and deep disease biology knowledge to generate insights and evidence for decision-making.
Total kidney volume (TKV) and beyond to understand treatment effects in ADPKD
Setting-up for success: our approach to imaging site set-ups
Underneath the lost kilos – using MRI-based body and muscle composition measurements to understand weight loss in clinical trials
Assessing treatment effects in liver cirrhosis and portal hypertension with an integrated imaging approach
Using imaging with gadoxetate to non-invasively assess liver function in clinical trials
Understanding the PK/PD effects of bi- and trimodal incretin agonists with quantitative PET imaging
Adding value to early clinical drug development in chronic kidney disease
Efficient and scalable delivery – Scaling up imaging solutions for global, multicentre, interventional trials
Seeing the holistic perspective – Cardiorenal
Precision – Focus on whole liver
Target engagement markers to take the right drug to the market – PET tracers
A holistic view of disease – Insulin resistance, T2D and Alzheimers
